Media Top News In The News Media Resources TOP NEWS November 04, 2025FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia August 11, 2025Biohaven Reports Second Quarter 2025 Financial Results and Recent Business Developments May 29, 2025Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor VIEW ALL WE ARE SOCIAL
